Detailled Information

Name of the Instrument/Tool Ankylosing Spondylitis-specific Arthritis Self-Efficacy Scale (ASES-AS)
First Description

Sandhu, Jaswant & Packham, Jon & Healey, Emma & Jordan, Kelvin & Garratt, Andrew & Haywood, Kirstie. (2011). Evaluation of a modified Arthritis Self-Efficacy Scale for an ankylosing spondylitis UK population. Clinical and experimental rheumatology. 29. 223-30. 

Year 2011
Domains
Concept of constructs Self-management
Population/Disease Disease specific
Originally developed for Ankylosing spondylitis (AS)
Other rheumatic diseases
where can be applied (only if validated)
---
Additional population with no rheumatic diseases No
Language: Originally published in English
Available in Language ---
REFERENCE IDENTIFICATION
Author/s Sandhu, Jaswant & Packham, Jon & Healey, Emma & Jordan, Kelvin & Garratt, Andrew & Haywood, Kirstie.
Title Evaluation of a modified Arthritis Self-Efficacy Scale for an ankylosing spondylitis UK population.
Journal Clinical and experimental rheumatology.
Year 2011
Vol 29
Num ---
Pages 223-30
Country UK
Language English
Other references of interest
Link http://www.ncbi.nlm.nih.gov/pubmed/10204758
Brief Description

The relationship of arthritis self-efficacy to daily pain, daily mood, and daily pain coping in rheumatoid arthritis patients.

Link https://europepmc.org/article/med/29573848
Brief Description

This SLR  aimed to identify studies investigating measurement properties of PROMs for spondyloarthritis, and to evaluate their methodological quality and level of evidence relating to the measurement properties of PROMs. 

Link https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158258/
Brief Description

This study examined psychometric properties of the 8-item English version of the Arthritis Self-Efficacy Scale (ASES-8) and differences in ASES-8 scores across sample subgroups.

Instrument/Tool Translations References
No other References.
DEVELOPER CONTACT INFORMATION
Correspondence to J Sandhu
E-Mail jsandhu@doctors.org.uk
Address Arthritis Research Campaign National Primary Care Centre, Keele University, Staffordshire, UK.
Website ---
Available ---
Links ---
DESCRIPTION OF THE INSTRUMENT
Type Of Measure Questionnaire
Brief Description

The original ASES was developed to measure patients’ arthritis-specific self-efficacy, or patients’ beliefs that they could perform specific tasks or behaviors to cope with the consequences of arthritis. It remains the most widely used arthritis-specific measure.

It  measures three SM constructs: pain self-efficacy, function self-efficacy and other symptoms self-efficacy. 8-item version includes two items from the pain subscale, four items from the other symptoms subscale, and two new items that relate to preventing pain and fatigue from interfering with daily activities.  

The ASES refers throughout to arthritis. The symptoms that AS patients experience are usually related to the spine and less frequently to peripheral joints, raising concerns that AS patients may not feel that assessing only arthritis encompasses their experience of disease. Therefore direct use of the ASES in an AS population is not feasible. In view of this, a rephrase of the ASES to specifically assess the impact of AS was conducted.

The ASES-AS is based on the 8-item ASES with minor alterations in phraseology. 

Number of Items 8 items
Range 1-10 for each subscale
Responses options/scale Yes
From ‘1 = very uncertain’ to ‘10 = very certain
Developed for Clinical practice, Research
PRACTICAL APPLICATION
Method of administration Interviewer/assessor, Self-administered
Recommendations to score

The score is the mean of the eight items. At least six items must be completed to obtain a score.

Score Interpretation Higher scores indicate higher self-efficacy.
Cut-off points ---
Cut-off points applied to ---
Smallest detectable change if described ---
Smallest detectable change applied to ---
Completion time by the patient <5 minutes
Scoring time by the assessor - minutes
Training to score Not necessary
Strengths Easy to use, Useful in clinical practice & research
Limitations Not widely used
OTHER COMMENTS
Other Comments ---